Judith van Loon

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. ncbi Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
    Judith van Loon
    Maastro Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands
    Lancet Oncol 13:e169-77. 2012
  2. ncbi 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW Research Institute, University Hospital Maastricht, Maastricht, The Netherlands
    Radiother Oncol 87:49-54. 2008
  3. ncbi Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW Research Institute, University Medical Centre, Dr Tanslaan 12, NL 6229 ET Maastricht, The Netherlands
    Eur J Cancer 45:588-95. 2009
  4. ncbi Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study
    Judith van Loon
    Department of Radiation Oncology, Maastro Clinic, GROW Research Institute, Maastricht University Medical Centre, Maastricht, The Netherlands
    Int J Radiat Oncol Biol Phys 77:329-36. 2010
  5. ncbi 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW Research Institute, Maastricht University Medical Centre, Maastricht, The Netherlands
    Eur J Cancer 46:110-9. 2010
  6. ncbi PET imaging of hypoxia using [18F]HX4: a phase I trial
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Eur J Nucl Med Mol Imaging 37:1663-8. 2010
  7. ncbi Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features
    Judith van Loon
    Department of Radiation Oncology, Maastro Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Int J Radiat Oncol Biol Phys 82:448-56. 2012
  8. ncbi Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer
    Judith van Loon
    Maastricht University Medical Centre, Department of Radiation Oncology, Maastro Clinic, GROW Research Institute, The Netherlands
    Cancer Treat Rev 37:331-43. 2011
  9. ncbi Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study
    Judith van Loon
    Department of Radiation Oncology, Maastricht University Medical Centre, The Netherlands
    Radiother Oncol 99:172-5. 2011

Detail Information

Publications9

  1. ncbi Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
    Judith van Loon
    Maastro Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands
    Lancet Oncol 13:e169-77. 2012
    ....
  2. ncbi 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW Research Institute, University Hospital Maastricht, Maastricht, The Netherlands
    Radiother Oncol 87:49-54. 2008
    ..To investigate the influence of selective irradiation of 18FDG-PET positive mediastinal nodes on radiation fields and normal tissue exposure in limited disease small cell lung cancer (LD-SCLC)...
  3. ncbi Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW Research Institute, University Medical Centre, Dr Tanslaan 12, NL 6229 ET Maastricht, The Netherlands
    Eur J Cancer 45:588-95. 2009
    ..Because the accuracy of (18)FDG-PET-CT is superior to CT, we hypothesised that FDG-PET-CT scans 3 months post-treatment could lead to early detection of progressive disease (PD) amenable for radical treatment...
  4. ncbi Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study
    Judith van Loon
    Department of Radiation Oncology, Maastro Clinic, GROW Research Institute, Maastricht University Medical Centre, Maastricht, The Netherlands
    Int J Radiat Oncol Biol Phys 77:329-36. 2010
    ..To evaluate the results of selective nodal irradiation on basis of (18)F-deoxyglucose positron emission tomography (PET) scans in patients with limited-disease small-cell lung cancer (LD-SCLC) on isolated nodal failure...
  5. ncbi 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW Research Institute, Maastricht University Medical Centre, Maastricht, The Netherlands
    Eur J Cancer 46:110-9. 2010
    ..Here, we report on the economic evaluation of this study...
  6. ncbi PET imaging of hypoxia using [18F]HX4: a phase I trial
    Judith van Loon
    Department of Radiation Oncology Maastro Clinic, GROW School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Eur J Nucl Med Mol Imaging 37:1663-8. 2010
    ..In this phase I trial, we aimed to determine the toxicity of [(18)F]HX4, a member of the 2-nitroimidazole family, at different dose levels. The secondary aim was to analyse image quality related to the HX4 dose and the timing of imaging...
  7. ncbi Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features
    Judith van Loon
    Department of Radiation Oncology, Maastro Clinic, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
    Int J Radiat Oncol Biol Phys 82:448-56. 2012
    ..The secondary aim was to establish the impact of these factors on the accuracy of positron emission tomography (PET) and computed tomography (CT) to assess the total tumor-bearing region at pathologic examination (CTV(path))...
  8. ncbi Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer
    Judith van Loon
    Maastricht University Medical Centre, Department of Radiation Oncology, Maastro Clinic, GROW Research Institute, The Netherlands
    Cancer Treat Rev 37:331-43. 2011
    ..Tracers other than (18)FDG are promising for treatment response assessment and the visualization of intra-tumor heterogeneity, but more research is needed before they can be clinically implemented...
  9. ncbi Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study
    Judith van Loon
    Department of Radiation Oncology, Maastricht University Medical Centre, The Netherlands
    Radiother Oncol 99:172-5. 2011
    ..The purpose of the current study was to evaluate whether CT or FDG metabolic response early after the start of chemotherapy, but before the beginning of chest RT, is predictive for survival in SCLC...